|
ZNF419 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 3.246000E-01 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
2.749800E-01 |
| Normal-vs-Stage2 |
7.231400E-01 |
| Normal-vs-Stage3 |
2.158800E-01 |
| Normal-vs-Stage4 |
2.774900E-04 |
| Stage1-vs-Stage2 |
8.543400E-01 |
| Stage1-vs-Stage3 |
6.636000E-02 |
| Stage1-vs-Stage4 |
4.640400E-03 |
| Stage2-vs-Stage3 |
2.488000E-01 |
| Stage2-vs-Stage4 |
2.504300E-02 |
| Stage3-vs-Stage4 |
1.002620E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
3.910800E-01 |
| Normal-vs-AfricanAmerican |
2.530600E-01 |
| Normal-vs-Asian |
8.432400E-01 |
| Caucasian-vs-AfricanAmerican |
5.359200E-01 |
| Caucasian-vs-Asian |
9.218000E-01 |
| AfricanAmerican-vs-Asian |
9.170200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
5.200000E-01 |
| Normal-vs-Female |
1.871600E-01 |
| Male-vs-Female |
3.494000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
3.128200E-01 |
| Normal-vs-Extreme_Weight |
8.656000E-01 |
| Normal-vs-Obese |
4.221600E-01 |
| Normal-vs-Extreme_Obese |
6.472400E-01 |
| Normal_Weight-vs-Extreme_Weight |
3.599600E-01 |
| Normal_Weight-vs-Obese |
7.563800E-01 |
| Normal_Weight-vs-Extreme_Obese |
9.362400E-01 |
| Extreme_Weight-vs-Obese |
5.226000E-01 |
| Extreme_Weight-vs-Extreme_Obese |
6.820200E-01 |
| Obese-vs-Extreme_Obese |
7.914600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
3.504800E-01 |
| Normal-vs-Age(41-60Yrs) |
1.806950E-01 |
| Normal-vs-Age(61-80Yrs) |
5.120200E-01 |
| Normal-vs-Age(81-100Yrs) |
2.709600E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
7.406800E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
5.498600E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
1.331240E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
5.124000E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
1.057780E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
2.330200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
1.282260E-02 |
| Normal-VS-Type2 PRCC |
9.991500E-04 |
| Normal-VS-KIRP CIMP |
6.134600E-01 |
| Normal-VS-Unclassified PRCC |
8.796800E-01 |
| Type1 PRCC-VS-Type2 PRCC |
1.23400000218155E-08 |
| Type1 PRCC-VS-KIRP CIMP |
7.934000E-01 |
| Type1 PRCC-VS-Unclassified PRCC |
6.415800E-02 |
| Type2 PRCC-VS-KIRP CIMP |
3.042100E-02 |
| Type2 PRCC-VS-Unclassified PRCC |
1.306120E-02 |
| KIRP CIMP-VS-Unclassified PRCC |
5.823800E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
6.190600E-01 |
| Normal-vs-N1 |
6.597200E-01 |
| Normal-vs-N2 |
2.780500E-03 |
| N0-vs-N1 |
9.398200E-01 |
| N0-vs-N2 |
8.629100E-04 |
| N1-vs-N2 |
6.476500E-03 |
|
|
